Skip to main content
Contact Us
Sign Up
Subscriber Sign In
English
日本語
navigation
Search
What We Do
Vantage
News
Analysis
Policy & Pricing
Data Insights
Events
Medtech
Therapy Areas
About Vantage
Editorial team
Products & Services
Consensus Forecasts
Pharma
EvaluatePharma
EvaluatePharma Vision
Custom Solutions
How We Can Help You
Pharma and Biotech
Medtech
Financial Services
Management Consultancies
Service Providers
Client Success
Customer Testimonials
Thought Leadership
About Us
Media Centre
Press Releases
Media Coverage
Executive Team
Vision & History
Careers
Current Vacancies
Contact Us
Sign Up for Vantage
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Policy & Pricing
Policy & Regulation
Pricing
Data Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
Primary tabs
View
(active tab)
Nycomed
December 16, 2015
Astra bets on respiratory with Daliresp deal
June 07, 2013
EP Vantage interview – MorphoSys mulls more R&D work after Glaxo deal
May 08, 2013
Inviragen buyout lifts Takeda vaccines strategy
April 23, 2013
BIO 2013 – Takeda’s small building blocks to recovery
March 20, 2013
Takeda’s NPS move does not alter US attraction or risk
February 12, 2013
Average M&A deal values fall back in 2012
February 07, 2013
M&A activity cools in 2012 as break-ups loom
December 13, 2012
Bausch + Lomb rumoured to be eyeing up buyers
November 20, 2012
Allergan’s SkinMedica deal shows dermatology action more than skin deep
October 08, 2012
EP Vantage interview – LigoCyte buy boosts Takeda’s vaccine business
September 14, 2012
EP Vantage Interview – Universal drug coverage nears in fast-growing Russia
Load More
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
July 31, 2019
Vantage Pharma, Biotech & Medtech Half-Year Review 2019
February 26, 2019
Vantage Pharma, Biotech and Medtech 2018 in Review
Editor's Picks
July 31, 2019
Car-T sales have disappointed, but has the sellside’s outlook shifted enough?
August 08, 2019
$1bn Corindus deal gets Healthineers off the acquisition blocks
August 07, 2019
Clovis investors feel more Lynparza pressure
August 02, 2019
A recap on the past few months of data digging and analysis
July 22, 2019
Oncology's haves and have-nots
